Capital Market
No description available for this analyst.
✅ Reliable Analyst
66
Score / 100
Performance Dashboard
Reliable analyst with a solid record of good picks.
Based on 11 IPO reviews in the last 12 months.
Accuracy
91%
Return Quality
75%
Consistency
64%
Horizon
89%
⚠️ Disclaimer: Past results are not guaranteed for future. This score only shows how well the analyst performed in the last 1 year. Use it for research only.
Review History
11 Total Reviews| IPO Name | Verdict | Listing Gain % | Total Gain % | Report |
|---|---|---|---|---|
| Aequs (Mainboard) | May apply | 12.90% | 13.10% | |
| Meesho (Mainboard) | Avoid | 0.00% | 33.41% | |
| Corona Remedies (Mainboard) | May apply | 38.42% | 38.85% | |
| Wakefit Innovations (Mainboard) | Neutral | 0.00% | -7.20% | |
| Park Medi World (Mainboard) | Neutral | -1.98% | -2.87% | |
| Nephrocare Health Services (Mainboard) | May apply | 6.52% | 14.43% | |
| KSH International (Mainboard) | Neutral | -3.65% | -6.05% | |
| Gujarat Kidney & Super Speciality (Mainboard) | Neutral | 5.26% | -6.66% | |
| Shadowfax Technologies (Mainboard) | Neutral | -9.19% | -6.39% | |
| Amagi Media Labs (Mainboard) | Neutral | -12.19% | 3.42% | |
| Bharat Coking Coal (Mainboard) | May apply | 95.65% | 62.87% |
